INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$15.0M

$14,999,931

Total Sells (Filtered)

$0

$0

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
NMRA P Neumora Therapeutics, Inc. ARCH Venture Partners XII, LLC • 10% Owner Discretionary BuyΔOwn +46.4% 2025-10-27 $4,999,977Large View Form 4 →
NMRA	Neumora Therapeutics, Inc.	ARCH Venture Partners XII, LLC 10% Owner Discretionary BuyΔOwn +46.4%	2025-10-27	$4,999,977Large	P	Form 4
NMRA P Neumora Therapeutics, Inc. ARCH Venture Partners X, LLC • 10% Owner Discretionary BuyΔOwn +46.4% 2025-10-27 $4,999,977Large View Form 4 →
NMRA	Neumora Therapeutics, Inc.	ARCH Venture Partners X, LLC 10% Owner Discretionary BuyΔOwn +46.4%	2025-10-27	$4,999,977Large	P	Form 4
NMRA P Neumora Therapeutics, Inc. Burow Kristina • Director Discretionary BuyΔOwn +46.4% 2025-10-27 $4,999,977Large View Form 4 →
NMRA	Neumora Therapeutics, Inc.	Burow Kristina Director Discretionary BuyΔOwn +46.4%	2025-10-27	$4,999,977Large	P	Form 4